Literature DB >> 9656453

Oxidised mannan antigen conjugates preferentially stimulate T1 type immune responses.

I F McKenzie1, V Apostolopoulos, C Lees, P X Xing, S Lofthouse, C Osinski, V Popovski, B Acres, G Pietersz.   

Abstract

It is desirable to be able to produce either T1 or T2 responses and we have found that, in mice, mannose--coupled antigens stimulated T2 type responses antibodies and CTLs, whereas if oxidized, mannose--coupled antigens stimulated T1 responses little antibody and a potent CTL response. In addition, the cytokine profiles support the T1rT2 differentiation with these immunizations, in that oxidized mannan antigen gives IFNg, IL-2 and IL-12 production, whereas in the absence of oxidization, IL-4 and not the other cytokines is produced. A number of antigens have been examined--particularly Mucin 1 and the delivery method using mannose may be applicable to the other antigens.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9656453     DOI: 10.1016/s0165-2427(98)00094-4

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  8 in total

1.  Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathway.

Authors:  Dodie S Pouniotis; Vasso Apostolopoulos; Geoffrey A Pietersz
Journal:  Immunology       Date:  2006-03       Impact factor: 7.397

Review 2.  Bioconjugate Strategies for the Induction of Antigen-Specific Tolerance in Autoimmune Diseases.

Authors:  Chunsong Yu; Jingchao Xi; Meng Li; Myunggi An; Haipeng Liu
Journal:  Bioconjug Chem       Date:  2017-12-06       Impact factor: 4.774

3.  Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells.

Authors:  Kuo-Ching Sheng; Dodie S Pouniotis; Mark D Wright; Choon Kit Tang; Eliada Lazoura; Geoffrey A Pietersz; Vasso Apostolopoulos
Journal:  Immunology       Date:  2006-07       Impact factor: 7.397

Review 4.  Carbohydrate-based immune adjuvants.

Authors:  Nikolai Petrovsky; Peter D Cooper
Journal:  Expert Rev Vaccines       Date:  2011-04       Impact factor: 5.217

Review 5.  Applications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseases.

Authors:  Akhilesh Kumar Shakya; Kutty Selva Nandakumar
Journal:  J R Soc Interface       Date:  2013-02       Impact factor: 4.118

6.  Coating of mannan on LPD particles containing HPV E7 peptide significantly enhances immunity against HPV-positive tumor.

Authors:  Zhengrong Cui; Su-Ji Han; Leaf Huang
Journal:  Pharm Res       Date:  2004-06       Impact factor: 4.200

7.  Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835].

Authors:  Vasso Apostolopoulos; Geoffrey A Pietersz; Anastasios Tsibanis; Annivas Tsikkinis; Heleni Drakaki; Bruce E Loveland; Sara J Piddlesden; Magdalena Plebanski; Dodie S Pouniotis; Michael N Alexis; Ian F McKenzie; Stamatis Vassilaros
Journal:  Breast Cancer Res       Date:  2006-06-15       Impact factor: 6.466

Review 8.  Targeting antigens to dendritic cell receptors for vaccine development.

Authors:  Vasso Apostolopoulos; Theresia Thalhammer; Andreas G Tzakos; Lily Stojanovska
Journal:  J Drug Deliv       Date:  2013-10-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.